Perrigo Company PLC (NYSE:PRGO) Given Average Rating of “Hold” by Brokerages

Perrigo Company PLC (NYSE:PRGO) has earned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $56.71.

PRGO has been the subject of a number of research reports. Wells Fargo & Co increased their price target on shares of Perrigo from $45.00 to $52.00 and gave the company a “market perform” rating in a report on Monday, September 30th. TheStreet raised shares of Perrigo from a “d+” rating to a “c-” rating in a report on Friday, September 27th. ValuEngine raised shares of Perrigo from a “sell” rating to a “hold” rating in a report on Wednesday, September 11th. Argus raised shares of Perrigo from a “hold” rating to a “buy” rating in a report on Friday, October 11th. Finally, SunTrust Banks raised their price objective on shares of Perrigo from $51.00 to $55.00 and gave the stock a “hold” rating in a report on Wednesday, September 25th. They noted that the move was a valuation call.

Shares of Perrigo stock opened at $53.90 on Friday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.92 and a quick ratio of 1.39. Perrigo has a fifty-two week low of $36.28 and a fifty-two week high of $75.42. The firm has a fifty day moving average price of $52.77 and a two-hundred day moving average price of $49.60. The company has a market cap of $7.40 billion, a PE ratio of 11.85, a price-to-earnings-growth ratio of 5.53 and a beta of 1.49.

Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.81 by $0.05. Perrigo had a net margin of 1.87% and a return on equity of 9.57%. The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same period in the prior year, the firm earned $1.22 EPS. The business’s revenue was down 3.2% on a year-over-year basis. Analysts expect that Perrigo will post 3.94 earnings per share for the current fiscal year.

In other Perrigo news, Director Theodore R. Samuels II acquired 4,000 shares of Perrigo stock in a transaction dated Friday, August 9th. The stock was bought at an average cost of $46.97 per share, with a total value of $187,880.00. Following the acquisition, the director now owns 8,236 shares of the company’s stock, valued at $386,844.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Ronald Winowiecki sold 826 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $48.03, for a total transaction of $39,672.78. Following the transaction, the chief financial officer now directly owns 6,952 shares of the company’s stock, valued at $333,904.56. The disclosure for this sale can be found here. 7.70% of the stock is currently owned by company insiders.

Large investors have recently added to or reduced their stakes in the company. First Trust Advisors LP boosted its stake in shares of Perrigo by 165.7% during the first quarter. First Trust Advisors LP now owns 704,468 shares of the company’s stock worth $33,927,000 after buying an additional 439,379 shares during the period. Amundi Pioneer Asset Management Inc. lifted its position in Perrigo by 26.6% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 130,128 shares of the company’s stock valued at $6,267,000 after purchasing an additional 27,379 shares during the period. Moon Capital Management LLC lifted its position in Perrigo by 67.3% in the second quarter. Moon Capital Management LLC now owns 43,909 shares of the company’s stock valued at $2,091,000 after purchasing an additional 17,660 shares during the period. Xact Kapitalforvaltning AB lifted its position in Perrigo by 18.1% in the second quarter. Xact Kapitalforvaltning AB now owns 26,707 shares of the company’s stock valued at $1,272,000 after purchasing an additional 4,092 shares during the period. Finally, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its position in Perrigo by 2.6% in the second quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 2,214,899 shares of the company’s stock valued at $105,473,000 after purchasing an additional 56,700 shares during the period. 87.69% of the stock is owned by institutional investors.

About Perrigo

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.

See Also: Understanding the Price to Earnings Ratio (PE)

Analyst Recommendations for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.